Sign in

CIK 0000812796

  • Non-accelerated filer
  • Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411505029
Phone
+1 609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-12-16 Brughera Marco Maria Director Purchase · Common Stock Warrant +2,500 $0.00 $0 2,500
2016-06-16 Krumeich Karen R SVP and CFO Grant or award · Option (Right to Buy) +100,000 100,000
2016-06-16 Brownlie Keith L Director Grant or award · Stock Option (Right to Buy) +40,541 40,541
2016-06-16 Brughera Marco Maria Director Grant or award · Stock Option (Right to Buy) +40,541 40,541
2016-06-16 LAPOINTE ANTHONY GREGG Director Grant or award · Stock Option (Right to Buy) +40,541 40,541
2016-06-16 ZELDIS JEROME B Director Grant or award · Stock Option (Right to Buy) +40,541 40,541
2016-06-16 RUBIN ROBERT J. Director Grant or award · Stock Option (Right to Buy) +40,541 40,541
2015-12-31 Warusz Joseph Michael VP of Finance/Acting CFO Grant or award · Option (Right to Buy) +55,000 55,000
2015-12-31 Straube Richard Senior VP and CMO Grant or award · Stock Option (Right to Buy) +70,000 70,000
2015-12-31 SCHABER CHRISTOPHER J Chairman, CEO and President Grant or award · Option (Right to Buy) +140,000 140,000
2015-12-31 Donini Oreola SVP and CSO Grant or award · Stock Option (Right to Buy) +70,000 70,000
2015-12-23 ZELDIS JEROME B Director Purchase +2,500 $1.27 $3K 69,166
2015-12-22 SCHABER CHRISTOPHER J Chairman, CEO and President Purchase +10,000 $1.29 $13K 85,761
2015-08-31 LAPOINTE ANTHONY GREGG Director Exercise or conversion +25,000 $0.30 $8K 73,781
2015-08-31 LAPOINTE ANTHONY GREGG Director Exercise or conversion · Common Stock Warrant −25,000 0
2015-07-01 SCHABER CHRISTOPHER J Chairman, CEO and President Exercise or conversion +7,143 $0.61 $4K 82,904
2015-07-01 SCHABER CHRISTOPHER J Chairman, CEO and President Exercise or conversion · Common Stock Warrant −7,143 0
2015-06-18 LAPOINTE ANTHONY GREGG Director Grant or award · Stock Option (Right to Buy) +19,868 19,868
2015-06-18 Brownlie Keith L Director Grant or award · Stock Option (Right to Buy) +19,868 19,868
2015-06-18 Brughera Marco Maria Director Grant or award · Stock Option (Right to Buy) +19,868 19,868

Page 10 of 14 · 277 trades